SEC 13F Intelligence

Foresite Capital Management IV, LLC / EIKN

Foresite Capital Management IV, LLC’s Eikon Therapeutics Inc Position

Does Foresite Capital Management IV, LLC own Eikon Therapeutics Inc (EIKN)? Yes1.94M shares worth $21M (+8.67% of its 13F portfolio) as of Q1 2026.

Position Value
$21M
Q1 2026
Shares
1.94M
% of Portfolio
+8.67%
Quarters Held
1
currently held

Position History EIKN

Reported value by quarter
Q1 ’26: $21MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.94M$21M+8.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of EIKN.